Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis
Ended Project Grant Awarded Last action
- Award ID
- R44AR074363
- Recipient
-
Xlock Biosciences, Inc. UEI LRVRYJKD2Q85
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,008,601
Award facts
- Assistance listing
- 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
- Completion date
- Originally
- Funding
-
- $2,179,503.95 Federal
- $829,097.00 Non-federal
- Place of performance
- Muskego, WI 53150, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$335,472 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $829,097 | $0 | |
| Amendment | $829,097 | $829,097 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $856,782 | $0 |
Quick answers
Who received award R44AR074363?
R44AR074363 was awarded to Xlock Biosciences, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 19, 2018.
How much is award R44AR074363 worth?
$3,008,601 has been obligated on R44AR074363: $2,179,504 in federal funding and $829,097 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award